All Episodes
Displaying 101 - 120 of 140 in total
Osteoarthritis... Mostly in the Knee, But Pick a Joint!!! Dr. Diem Nguyen, CEO of Xalud Therapeutics
Osteoarthritis – mostly in the knee, but pick a joint. Dr. Diem (Zem) Nguyen (N’Win) is the CEO of Xalud (Za-lood) Therapeutics. We’ll talk about their work to reduce ...
Why Do AI One Way, When You Can Do it 25??? Dr. Ben Thomas and Dermot Tierney, CEO & CCO, Amply Discovery
Why use one AI approach when you can use 25? CEO Dr. Ben Thomas and Chief Commercial Officer Dermot Tierney from Amply Discovery talks about how their novel approach t...
Acute Cannabis Intoxication... Is There An Antidote??? Dr. Ken Cundy, CSO at Anebulo Pharmaceuticals
Modern cannabis products, with higher potency than those from the past, can lead to acute cannabis intoxication. Anebulo Pharmaceuticals, led by Chief Scientific Offic...
Gliobastoma + New View on Clinical Trials... Dr. Fahar Merchant, President & CEO Medicenna Therapeutics
Glioblastoma is the most aggressive form of brain cancer, and progress in treating Glioblastoma has been elusive. Now, Toronto-based Medicenna has completed a successf...
Innovation in Head & Neck Cancers!!! Dr. Mark Newman, CSO, GeoVax
In this week's BioTech Nation, we discuss Geovax, a company working on a novel approach to treat head and neck cancers, which are often difficult to treat after standa...
We Still Can't Ignore Long Covid... Dr. Jeffrey Cleland, CEO Ashvattha Therapeutics
In this week's episode of Biotech Nation, Dr. Jeffrey Cleland, the President and CEO of Ashvattha Therapeutics, discusses their drug development efforts to address lon...
Can The Time Needed for CAR-T be shortened? EXUMA Says Yes!!! Dr. Gregory Frost, CEO, EXUMA Biotech
In this week's episode of Biotech Nation, Dr. Greg Frost, CEO of Exuma Biotech, discusses their innovative approaches to cancer treatment. They are working on a method...
Temporal Lobe Epilepsy - TLE - Will Cell Therapy Work??? Dr. Cory Nicholas, CEO, Neurona Therapeutics
A new cell therapy, just entering human clinical trials. It focuses on a particular type of Epilepsy - Temporal Lobe Epilepsy. I speak with Dr. Cory Nicholas, the Co-F...
New Hope For Glaucoma... Dr. Chris Nave, Managing Director of Brandon Capital and Chair of PolyActiva
Join us as Dr. Chris Nave, the managing director of Brandon Capital and Chair of PolyActiva, reveals groundbreaking advancements in eye treatments on this week's episo...
The Beauty Contest... Winner Goes to Phase I - Dr. Richard Austin, Founder & CEO Reglagene
Join Dr. Richard Austin, Founder and CEO of Reglagene, as he reveals the intense process of selecting the most promising drug candidate for treating brain cancer. Delv...
Sticky Proteins??? Alzheimer's, Parkinson's, and ALS...Dr. Maria Maccecchini, President & CEO, Annovis Bio
This week we explore the commonalities among neurodegenerative disorders such as Alzheimer's, Parkinson's, and ALS. Dr. Maria Macccecchini, Founder and CEO of Annovis ...
When Your Distant Cousins ID You For Murder… Ed Humes, Author of "The Forever Witness"
Moira speaks with Pulitzer Prize-winning author, Ed Humes. His latest is “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double Murder.” We get an obje...
Are Fibroblasts All Over My Body??? Dr. Hamid Khoja, CSO at FibroBiologics
Dr. Hamid Khoja, Chief Scientific Officer of Fibro Biologics, discusses the potential of fibroblasts in regenerative medicine, highlighting their abundance and diverse...
Engineering Viruses to Treat Solid Tumors... Dr. Paul Peter Tak, CEO of Candel Therapeutics
Dr. Paul Peter Tack, CEO of Candel Therapeutics, unveils their groundbreaking approach to cancer treatments using engineered viruses. Discover how these viruses are ha...
AI Three Different Ways to a New Drug??? Dr. Francois Vigneault, Co-Founder & CEO Shape Therapeutics
Discover the limitless potential of mRNA engineering as Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, discusses their groundbreaking work in using ...
Fighting the Most Advanced Prostate Cancer... Dr. Philip Kantoff, CEO Convergent Therapeutics
200,000 men at diagnosed each year with Prostate cancer … beginning a journey of many successive treatments. Still, 35,000 men die as a result of prostate cancer. Conv...
A Different Approach, A New Cancer Drug... Dr. Paul Lammers, CEO Triumvira Immunologics
Cancer treatments which work with the immune system are making great strides, with Keytruda from Merck being perhaps the best known. Still there is much work to be don...
Are Your Genes Failing You??? Dr. Noah Davidsohn, Co-Founder & CSO Rejuvenate Bio
Dr. Nolan Davidson, the Co-Founder and Chief Scientific Officer of Rejuvenate Bio, discusses the importance of regulating protein expression and the role it plays in a...
25 Years in the Making - Treatment in Schleroderma? Dr. Darren Kelly, CEO, Certa Therapeutics
Dr. Darren Kelly, a professor and researcher at the University of Melbourne and the Founder and CEO of Certa Therapeutics, tells us about their clinical trials address...
Fatty Liver, NASH, Cirrhosis - Can They Be Stopped??? Dr. Robert Foster, CEO Hepion Pharmaceuticals
Did you know that 1 in 4 Americans suffer from fatty liver disease? And that can lead to a more serious condition called Nash, which can ultimately cause cirrhosis of ...
